hydroxyproline has been researched along with navitoclax in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Chung, EJ; Citrin, DE; Hauer-Jensen, M; Huang, L; Li, D; Lin, S; Meng, A; Pan, J; Wang, Y; Xu, Y; Zhang, J; Zhou, D | 1 |
1 other study(ies) available for hydroxyproline and navitoclax
Article | Year |
---|---|
Inhibition of Bcl-2/xl With ABT-263 Selectively Kills Senescent Type II Pneumocytes and Reverses Persistent Pulmonary Fibrosis Induced by Ionizing Radiation in Mice.
Topics: Alveolar Epithelial Cells; Aniline Compounds; Animals; Antineoplastic Agents; bcl-2-Associated X Protein; beta-Galactosidase; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p16; Cytokines; Hydroxyproline; Inflammation Mediators; Lung; Male; Mice; Mice, Inbred C57BL; Polymerase Chain Reaction; Proto-Oncogene Proteins c-bcl-2; Radiation Pneumonitis; Radiation, Ionizing; RNA, Messenger; Sulfonamides | 2017 |